Biovica International AB (publ)

kr 0.31As of Sun 8 Nov 2026, 12:00 UTC
STO:BIOVIC-BHealthcare
Country Sweden
PE (Fwd) •••
TSR 10Y CAGR (31.77%)
Div yield —
ROE (156.59%)
Biotechnology
Beta (5Y) 1.24
PE TTM —
TSR TTM (36.12%)
Mkt cap kr 91.37M
ROIC (87.48%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 0.376
20.22%
21.03%
Hold 12|11|9|7|9
2Q26
3Q26
4Q26
1Q27
Earnings per sharekr
—
—
—
—
(0.15%)
10.46%
18.99%
17.04%
Revenuekr M
5.370
5.256
5.460
5.329
6.49%
1.48%
3.34%
0.33%
Peers (US$9.237M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
1.701
0.065
0.085
EBIT/Intx
0.699
1.332
1.094
Own earn%
(106.81)
(17.40)
(20.13)
Sh yield%
22.84
36.34
33.89
Owners
Insiders/Inst%
5.10
57.82
Short interest%
1.25
SBC / revenue%
1.45
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
25–31
$1 testx
1.0
Incr. ROIC%
6